M.J. Welsh and A.E. Smith, RAC Application 
67. Sheppard, D. N., D. P. Rich, R. JH. Gregory, D. W. Souza, A. E. Smith, and M. J. Welsh. 
1992. Function of CFTR containing mutations in the First membrane spanning domain 
that are associated with mild disease. Pediatr Pulmon suppl 8:250.(Abstr.) 
68. Strong, T. V., L. S. Smit, S. V. Turpin, J. L. Cole, C. T. Hon, D. Markiewicz, T. L. Petty, 
M. W. Craig, E. C. Rosenow, L. C. Tsui, and et-al. 1991. Cystic fibrosis gene mutation in 
two sisters with mild disease and normal sweat electrolyte levels. N Engl. J Med 
325:1630-1634. 
69. Hille, B. 1984. Ionic channels in excitable membranes. Sinauer Associates Inc, 
Sunderland, MA. 426 pp. 
70. Trapnell, B. C., C. S. Chu, P. K. Paakko, T. C. Banks, K. Yoshimura, V. J. Ferrans, M. S. 
Chemick, and R. G. Crystal. 1991. Expression of the cystic fibrosis transmembrane 
conductance regulator gene in the respiratory tract of normal individuals and individuals 
with cystic fibrosis. Proc Natl Acad Sci. U. S. A. 88:6565-6569. 
71. Whitsett, J. A., C. R. Dey, B. R. Stripp, K. A. Wikenheiser, J. C. . Clark, S. E. Wert, R. J. 
Gregory, A. E. Smith, J. A. Cohn, J. M. Wilson, and J. Engelhardt. 1992. Human cystic 
fibrosis transmembrane conductance regulator directed to respiratory epithelial cells of 
transgenic mice. Nature Gen 2:13-20. 
72. DiTullio, P., S. H. Cheng, J. Marshall, R. J. Gregory, K. M. Ebert, H. M. Meade, and A. 
E. Smith. 1992. Production of Cystic Fibrosis Transmembrane Conductance Regulator in 
the Milk of Transgenic Mice. Bio/Technology 10:74-77. 
73. Stone, K. C., R. R. Mercer, P. Gehr, B. Stockstill, and J. D. Crapo. 1992. Allometric 
relationships of cell numbers and size in the mammalian lung. Am J Respir Cell Mol Biol 
6:2335-2343. 
74. Weiss, R.A., N. Teich, H.E. Varmers, and J. Cottin. 1984. RNA Tumor Virus. Cold 
Spring Harbor, Cold Spring Harbor. 
75. Horwitz, M. S. 1991. Adenoviridae and their replication. In Fields Virology. B.N. Fields, 
editor. Raven Press, New York. 
76. Ginsberg, H.S. 1984. The Adenoviruses. Plenum Press, New York. 
77. Tooze, J. 1984. DNA Tumour Viruses. Cold Spring Harbor, Cold Spring Harbor. 
78. Abken, H., C. Butzler, and K. Willecke. 1987. Adenovirus type 5 persisting in human 
lymphocytes is unlikely to be involved in immortalization of lymphoid cells by fusion 
with cytoplasts or by transfection with DNA of mouse cells. Anticancer Res 7:553-558. 
79. Chu, Y., K. Sperber, L. Mayer, and M. -T. Hsu. 1992. Persistent infection of human 
adenovirus type 5 in human monocyte cell lines. Virology 188:793-800. 
80. Graham, F. L. and L. Prevec. 1992. Adenovirus-based expression vectors and 
recombinant vaccines. In Vaccines: New Approaches to Immunological Problems. R.W. 
Ellis, editor. Butterworth-Heinemann, Boston. 363-390. 
81. Graham, F. L., J. Smiley, W. L. Russell, and R. Naim. 1977. Characterization of a human 
cell line transformed by DNA from adenovirus 5. J Gen Virol 36:59-72. 
[930] 
Recombinant DNA Research, Volume 16 
